INDV - Indivior Pharmaceuticals Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$44.67
DETAILS
HIGH:
$50.00
LOW:
$36.00
MEDIAN:
$48.00
CONSENSUS:
$44.67
UPSIDE:
19.02%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 1,239 | 1,188 | 1,093 | 901 | 791 | 647 | 785 | 959.9 | 1,148.1 | 968.9 |
| Cost of Revenue | 246 | 231 | 174 | 151 | 127 | 97 | 140 | 134.7 | 122.9 | 110.8 |
| Gross Profit | 993 | 957 | 919 | 750 | 664 | 550 | 645 | 825.2 | 1,025.2 | 858.1 |
| Operating Expenses | ||||||||||
| R&D Expenses | 97 | 107 | 116 | 74 | 52 | 40 | 53 | 64.0 | 93.5 | 109.0 |
| SG&A Expenses | 634 | 618 | 569 | 469 | 431 | 649 | 395 | 444.1 | 508.4 | 411.2 |
| Other Expenses | (3) | 200 | 390 | 288 | (32) | 17 | 19 | 0 | 0 | 0 |
| Operating Expenses | 728 | 925 | 1,075 | 831 | 451 | 706 | 467 | 508.1 | 601.9 | 520.2 |
| Operating Income | ||||||||||
| Operating Income | 265 | 32 | (156) | (81) | 213 | (156) | 178 | 317.1 | 423.3 | 337.9 |
| Interest Expense | 45 | 41 | 35 | 29 | 26 | 24 | 22 | 31 | 49 | 51 |
| Interest Income | 22 | 23 | 43 | 19 | 4 | 7 | 24 | 17 | 7 | 0 |
| Profitability | ||||||||||
| EBITDA | 304 | 84 | (99) | (46) | 238 | (123) | 230 | 310.4 | 437.0 | 149.3 |
| EBIT | 284 | 55 | (114) | (62) | 216 | (149) | 202 | 295.1 | 193 | 136.4 |
| Income Before Tax | 239 | 14 | (149) | (89) | 190 | (173) | 180 | 265.5 | 143.9 | 89.7 |
| Income Tax Expense | 29 | 11 | (20) | (44) | (15) | (25) | 46 | 2.9 | 83.0 | 57.7 |
| Net Income | 210 | 2 | (129) | (44) | 205 | (148) | 134 | 262.7 | 60.9 | 32.1 |
| Per Share Data | ||||||||||
| EPS (Basic) | 1.68 | 0.02 | 0.01 | -0.37 | 1.38 | -1.08 | 0.95 | 1.81 | 0.42 | 0.22 |
| EPS (Diluted) | 1.64 | 0.01 | 0.01 | -0.37 | 1.31 | -1.08 | 0.92 | 1.75 | 0.41 | 0.22 |
| Shares Outstanding | 125 | 132 | 137.3 | 139.0 | 145.7 | 146.6 | 146.0 | 145.4 | 144.2 | 144.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 195 | 319 | 316 | 778.2 | 1,102 | 858 | 1,060 | 924.0 | 863.0 | 692.0 |
| Short-Term Investments | 0 | 1 | 94 | 119.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 255 | 254 | 254 | 220 | 202 | 219 | 204 | 278 | 257 | 205 |
| Inventory | 153 | 178 | 135 | 114.6 | 95 | 93 | 73 | 78.0 | 52.0 | 41.0 |
| Other Current Assets | 15 | 87 | 444 | 18 | 27 | 0 | 0 | 49.0 | 38 | 40 |
| Total Current Assets | 652 | 839 | 1,266 | 1,265.8 | 1,444 | 1,187 | 1,360 | 1,329.0 | 1,225.0 | 990.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 170 | 139 | 124 | 85.5 | 95 | 103 | 107 | 57.0 | 54.0 | 27.0 |
| Goodwill | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2 | 5 | 13 | 70 | 82 | 62 | 72 | 0 | 0 | 0 |
| Long-Term Investments | 28 | 26 | 41 | 98.5 | 0 | 0 | 0 | 33.0 | 15.0 | 0 |
| Other Non-Current Assets | 26 | 29 | 28 | 38.6 | 106 | 104 | 73 | 84.0 | 92.0 | 83.0 |
| Total Non-Current Assets | 552 | 481 | 499 | 512.8 | 388 | 344 | 292 | 218.0 | 219.0 | 219.0 |
| Total Assets | 1,204 | 1,319 | 1,765 | 1,778.6 | 1,832 | 1,531 | 1,652 | 1,547.0 | 1,444.0 | 1,209.0 |
| Current Liabilities | ||||||||||
| Account Payables | 48 | 63 | 39 | 33 | 26 | 416 | 499 | 47 | 40 | 33 |
| Short-Term Debt | 39 | 18 | 12 | 3 | 3 | 12 | 9 | 4 | 5 | 101 |
| Deferred Revenue | 0 | 0 | 0 | 9.0 | 0 | 0 | 0 | 24.0 | 41.0 | 52.0 |
| Other Current Liabilities | 722 | 802 | 1,159 | 391 | 635 | 156 | 195 | 603.0 | 617.0 | 673 |
| Total Current Liabilities | 914 | 939 | 1,290 | 1,024.5 | 804 | 599 | 742 | 818.0 | 854.0 | 1,030.0 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 290 | 315 | 237 | 237 | 239 | 230 | 233 | 237 | 477 | 434 |
| Deferred Tax Liabilities | 3 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 73 | 381 | 390 | 436.8 | 550 | 577 | 417 | 426.0 | 316.0 | 40.0 |
| Total Non-Current Liabilities | 388 | 728 | 666 | 702.8 | 825 | 850 | 701 | 663.0 | 793.0 | 474.0 |
| Total Liabilities | 1,302 | 1,667 | 1,956 | 1,727.3 | 1,629 | 1,449 | 1,443 | 1,481.0 | 1,647.0 | 1,504.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 62 | 62 | 68 | 68.4 | 70 | 73 | 73 | 73.0 | 72.0 | 72.0 |
| Retained Earnings | (243) | (454) | (295) | 1,310.0 | 1,438 | 1,311 | 1,449 | 1,315.0 | 1,032.0 | 950.0 |
| Accumulated Other Comprehensive Income | (30) | (46) | (1,348) | (1,335.2) | 0 | (1,308) | (1,318) | (1,327.0) | (1,309.0) | (1,317.0) |
| Total Stockholders' Equity | (98) | (348) | (191) | 51.3 | 203 | 82 | 209 | 66.0 | (203.0) | (295.0) |
| Total Liabilities & Equity | 1,204 | 1,319 | 1,765 | 1,778.6 | 1,832 | 1,531 | 1,652 | 1,547.0 | 1,444.0 | 1,209.0 |
| Debt Metrics | ||||||||||
| Total Debt | 351 | 375 | 283 | 277 | 286 | 285 | 293 | 241.0 | 482.0 | 535.0 |
| Net Debt | 156 | 56 | (33) | (501.2) | (816) | (573) | (767) | (683.0) | (381.0) | (157.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 210 | 2 | (129) | (44) | 213 | (156) | 178 | 262.7 | 60.9 | 32.1 |
| Depreciation & Amortization | 20 | 29 | 15 | 16 | 22 | 26 | 28 | 15.3 | 13.7 | 12.8 |
| Stock-Based Compensation | 26 | 24 | 21 | 16 | 11 | 8 | 3 | 0 | 0 | 0 |
| Change in Working Capital | (257) | (41) | (294) | 118 | 173 | (19) | (79) | 27.7 | 148.1 | 309.5 |
| Other Non-Cash Items | 20 | 16 | 87 | (110) | (66) | (52) | 21 | 20.1 | 177.5 | (65.0) |
| Operating Cash Flow | (27) | 36 | (300) | (4) | 353 | (193) | 151 | 289.4 | 309.9 | 372.7 |
| Investing Activities | ||||||||||
| Capital Expenditure | (66) | (29) | (53) | (5) | (34) | (4) | (7) | (39.2) | (45.2) | (32.1) |
| Acquisitions | 0 | 0 | (129) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (20) | (17) | (45) | (245) | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 117 | 129 | 27 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 20 | (2) | (42) | 1 | (10) | 0 | 5 | 35.3 | 0 | 0 |
| Investing Cash Flow | (66) | 69 | (95) | (222) | (14) | (4) | (2) | (3.8) | (45.2) | (32.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (17) | 92 | (12) | (3) | 14 | (4) | (4) | (229.2) | (86) | (78) |
| Stock Repurchased | (11) | (173) | (33) | (90) | (101) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (63.2) |
| Other Financing Activities | (4) | (24) | (22) | (10) | (8) | (7) | (9) | (10.8) | 0 | 12.4 |
| Financing Cash Flow | (30) | (102) | (64) | (101) | (94) | (10) | (13) | (226.4) | (88.2) | (134.6) |
| Cash Position | ||||||||||
| Net Change in Cash | (124) | 3 | (458) | (328) | 244 | (202) | 136 | 61.0 | 171.0 | 206.0 |
| Cash at Beginning | 319 | 316 | 774 | 1,102 | 858 | 1,060 | 924 | 863.0 | 692.0 | 486.0 |
| Cash at End | 195 | 319 | 316 | 774 | 1,102 | 858 | 1,060 | 924.0 | 863.0 | 692.0 |
| Free Cash Flow | (93) | 7 | (353) | (9) | 319 | (197) | 144 | 250.2 | 264.7 | 340.7 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1,239 | 1,188 | 1,093 | 901 | 791 | 647 | 785 | 959.9 | 1,148.1 | 968.9 |
| Gross Profit | 993 | 957 | 919 | 750 | 664 | 550 | 645 | 825.2 | 1,025.2 | 858.1 |
| Operating Income | 265 | 32 | (156) | (81) | 213 | (156) | 178 | 317.1 | 423.3 | 337.9 |
| Net Income | 210 | 2 | (129) | (44) | 205 | (148) | 134 | 262.7 | 60.9 | 32.1 |
| EPS (Diluted) | 1.64 | 0.01 | 0.01 | -0.37 | 1.31 | -1.08 | 0.92 | 1.75 | 0.41 | 0.22 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 195 | 319 | 316 | 778.2 | 1,102 | 858 | 1,060 | 924.0 | 863.0 | 692.0 |
| Total Assets | 1,204 | 1,319 | 1,765 | 1,778.6 | 1,832 | 1,531 | 1,652 | 1,547.0 | 1,444.0 | 1,209.0 |
| Total Debt | 351 | 375 | 283 | 277 | 286 | 285 | 293 | 241.0 | 482.0 | 535.0 |
| Stockholders' Equity | (98) | (348) | (191) | 51.3 | 203 | 82 | 209 | 66.0 | (203.0) | (295.0) |
| Cash Flow | ||||||||||
| Operating Cash Flow | (27) | 36 | (300) | (4) | 353 | (193) | 151 | 289.4 | 309.9 | 372.7 |
| Capital Expenditure | (66) | (29) | (53) | (5) | (34) | (4) | (7) | (39.2) | (45.2) | (32.1) |
| Free Cash Flow | (93) | 7 | (353) | (9) | 319 | (197) | 144 | 250.2 | 264.7 | 340.7 |